News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
After setbacks, cell therapy for glioblastoma moves onto new chapter
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.
NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases
NIH, FDA, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for rare diseases.
Webinar Recording: Penn at the B.PHL
The session, titled Feminine Energy: Female Founders Solving Sustainability Challenges, was a panel format featuring a Penn spinout, Pennovation tenants, and a Penn partner.
Scout Bio raises $4.75M to advance gene therapy for pets
The company has now raised more than $35 million since its inception.
Announcing the 2022 Y-Prize: Win $10k For Your Ideas!
For ten years, the Y-Prize Competition has brought Penn students together to unleash their creativity, build their entrepreneurial skills—and win money along the way.
Webinar Recording: New Patenting Strategies for Life Science Inventors
Webinar hosted by the Penn Center for Innovation with Dr. Kathryn Doyle, Partner, Saul Ewing Arnstein & Lehr.
Webinar Recording: Penn Health-Tech
Katherine Reuther, Ph.D., MBA, Executive Director of the Penn Center for Health-Devices and Technology discusses resources to support your medical device idea.
Three of the top 20 highest-valued Philadelphia area startups are Penn spinouts
The Philadelphia Business Journal recently ranked the 20 highest-valued startups in Greater Philadelphia.
Success stories in gene therapy
Scientific American recently featured four stories on advancements in gene therapy.
Novel gene therapy platform speeds search for ways to cure blindness
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders.